Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21558047rdf:typepubmed:Citationlld:pubmed
pubmed-article:21558047lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:21558047lifeskim:mentionsumls-concept:C1265292lld:lifeskim
pubmed-article:21558047lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:21558047lifeskim:mentionsumls-concept:C0004610lld:lifeskim
pubmed-article:21558047lifeskim:mentionsumls-concept:C1719672lld:lifeskim
pubmed-article:21558047lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:21558047lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:21558047pubmed:issue3lld:pubmed
pubmed-article:21558047pubmed:dateCreated2011-6-20lld:pubmed
pubmed-article:21558047pubmed:abstractTextUSA300 methicillin-resistant Staphylococcus aureus (MRSA) is increasing as a cause of severe community-associated bacteremic infections. We assessed severe sepsis in response to infection in patients with USA300 MRSA compared to non-USA300 MRSA bacteremia. A cohort study was conducted from 1997 to 2008 comparing sepsis in response to infection in 271 patients with MRSA bacteremia from 4 VA hospitals. Sixty-seven (25%) patients with MRSA bacteremia were USA300 MRSA; 204 (75%) were non-USA300 MRSA. The proportion of MRSA bacteremia caused by USA300 MRSA increased over time (?² P < 0.0001). Adjusting for age and nosocomial infection, patients with USA300 MRSA bacteremia were more likely to have severe sepsis or septic shock in response to infection than patients with non-USA300 MRSA bacteremia (adjusted relative risk = 1.82; 95% confidence interval, 1.16-2.87; P = 0.01). This suggests that patients with USA300 MRSA are more likely to develop severe sepsis in response to their infection, which could be due to host or bacterial differences.lld:pubmed
pubmed-article:21558047pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21558047pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21558047pubmed:languageenglld:pubmed
pubmed-article:21558047pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21558047pubmed:citationSubsetIMlld:pubmed
pubmed-article:21558047pubmed:statusMEDLINElld:pubmed
pubmed-article:21558047pubmed:monthJullld:pubmed
pubmed-article:21558047pubmed:issn1879-0070lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:RoghmannMary-...lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:StineO...lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:ClimoMichael...lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:PerencevichEl...lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:LesseAlan JAJlld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:GordinFred...lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:KreiselKriste...lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:ShardellMiche...lld:pubmed
pubmed-article:21558047pubmed:authorpubmed-author:JohnsonJ...lld:pubmed
pubmed-article:21558047pubmed:copyrightInfoCopyright © 2011 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:21558047pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21558047pubmed:volume70lld:pubmed
pubmed-article:21558047pubmed:ownerNLMlld:pubmed
pubmed-article:21558047pubmed:authorsCompleteYlld:pubmed
pubmed-article:21558047pubmed:pagination285-90lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:meshHeadingpubmed-meshheading:21558047...lld:pubmed
pubmed-article:21558047pubmed:year2011lld:pubmed
pubmed-article:21558047pubmed:articleTitleUSA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?lld:pubmed
pubmed-article:21558047pubmed:affiliationUniversity of Maryland Baltimore, Baltimore, MD 21201, USA. kris03222001@yahoo.comlld:pubmed
pubmed-article:21558047pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21558047pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21558047pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed